PHARMACEUTICAL PREPARATION MANUFACTURING · MEDICINAL AND BOTANICAL MANUFACTURING
Work mix: 100% prime · 0% sub · primary NAICS 325412 / PSC 6505 DRUGS AND BIOLOGICALS
Recompete exposure: None
No incumbent recompetes detected in the next 24 months.
$90 for 90 days · $1 a day · one recompete pays for a decade of it.
Verify any number on this page. The analysis is the part you can't self-serve.
Start your 90-day capture sprint — $90 →Incumbents win 70–80% of recompetes.
90 days · $90 · no annual contract · cancel anytime
No incumbent recompetes detected in the next 24 months.
No incumbent recompetes detected in the next 24 months.
$1 a day. One recompete pays for a decade.
This page stays free — verify any figure yourself. Pilot is the live layer: displacement scoring, alerts, and a 90-day capture workflow you can't self-serve.
“SCOUT saves the hours of analysis that capture and proposal teams cannot afford to lose by delivering analyzed intelligence. Incumbent history, competitive positioning, and agen…”
Live displacement scoring, competitive landscape, and alerts. Run the full 90-day sprint — $90.
90 days · $90 · no annual contract · cancel anytime
Others competing in Fresenius Kabi's NAICS lane — open a profile to compare footprint and recompetes.
Browse live recompete landscapes by vehicle, agency, and set-aside.
Submit your UEI and we’ll generate your federal profile. We’ll email you when it’s live.
Query this company live in SCOUT via MCP — personalized displacement scoring, alerts, and capture workflow. Learn about SCOUT MCP → · Start a $90 Pilot →
Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows. Explore it live — $90 Pilot →